<code id='9FFA5865CB'></code><style id='9FFA5865CB'></style>
    • <acronym id='9FFA5865CB'></acronym>
      <center id='9FFA5865CB'><center id='9FFA5865CB'><tfoot id='9FFA5865CB'></tfoot></center><abbr id='9FFA5865CB'><dir id='9FFA5865CB'><tfoot id='9FFA5865CB'></tfoot><noframes id='9FFA5865CB'>

    • <optgroup id='9FFA5865CB'><strike id='9FFA5865CB'><sup id='9FFA5865CB'></sup></strike><code id='9FFA5865CB'></code></optgroup>
        1. <b id='9FFA5865CB'><label id='9FFA5865CB'><select id='9FFA5865CB'><dt id='9FFA5865CB'><span id='9FFA5865CB'></span></dt></select></label></b><u id='9FFA5865CB'></u>
          <i id='9FFA5865CB'><strike id='9FFA5865CB'><tt id='9FFA5865CB'><pre id='9FFA5865CB'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:34
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          The CDC's new social media misinformation war
          The CDC's new social media misinformation war

          KIRILLKUDRYAVTSEV/AFP/GettyImagesYou’rereadingthewebeditionofD.C.Diagnosis,STAT’stwice-weeklynewslet

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

          CarstenSnejbjerg/BloombergLONDON—TheinvestmentarmofNovoNordisk’sparentfoundationisbuyingdrugmanufact